POTENSI STIMULASI SENSORIK GAMMA NONINVASIF PADA PASIEN GERIATRI DENGAN PENYAKIT ALZHEIMER: TINJAUAN LITERATUR
NON-INVASIVE GAMMA SENSORY STIMULATION POTENTIAL IN GERIATRIC ALZHEIMER’S PATIENTS: A LITERATURE REVIEW
Abstract
Alzheimer's disease (AD) is one of the common health problems faced by the elderly, which can affect cognitive abilities and brain function. Currently available therapies are not very effective in managing AD in some people, so there is still a need for other treatment innovations in improving the QoL of patients. So this innovation presented with the aim to exploring the effectiveness of gamma sensory stimulation in preventing white matter atrophy and myelin loss, and its impact on cognitive decline. This research is a literature review sourced from several internet search engines. The review conducted through several stages, including identification, screening, and fulfillment inclusion and exclusion criteria, and finally resulting in 7 articles. The use of this device as therapy in geriatric patients with AD has been clinically tested and shown positive results in overcoming white matter atrophy and myelin loss in geriatric patients with AD. By improving these conditions, the device has the potential to slow the progression or even reduce symptoms experienced by patients, such as cognitive decline. Thus, based on the findings of this study, gamma stimulation could be a potential complementary therapy for Alzheimer's patients, thereby improving their quality of life.
Abstrak
Penyakit alzheimer (AD) merupakan salah satu masalah kesehatan yang sangat sering dihadapi oleh lansia (usia 60 tahun keatas), yang dapat mempengaruhi kemampuan kognitif serta fungsi otak. Terapi yang tersedia saat ini belum begitu efektif dalam mengelola AD pada beberapa orang, sehingga masih diperlukan inovasi pengobatan lainnya dalam meningkatkan kualitas hidup pasien. Sehingga inovasi ini dihadirkan dengan tujuan untuk mengeksplorasi efektivitas stimulasi sensorik gamma dalam mencegah atrofi materi putih dan kehilangan mielin, serta dampaknya terhadap penurunan kognitif. Penelitian ini merupakan kajian pustaka yang bersumber dari beberapa mesin pencari internet. Kajian dilakukan melalui beberapa tahap, meliputi identifikasi, penyaringan, dan pemenuhan kriteria inklusi dan eksklusi, sehingga menghasilkan 7 artikel yang memenuhi kriteria inklusi. Penggunaan alat ini sebagai terapi pada pasien geriatri dengan AD telah teruji secara klinis dan menunjukkan hasil yang positif dalam mengatasi atrofi materi putih dan kehilangan mielin pada pasien geriatri dengan AD. Dengan memperbaiki kondisi ini, alat ini berpotensi memperlambat progresi atau bahkan mengurangi gejala yang dialami pasien, seperti penurunan kognitif. Sehingga, berdasarkan temuan kajian ini, stimulasi gamma bisa menjadi terapi pelengkap yang potensial untuk pasien Alzheimer, sehingga meningkatkan kualitas hidup pasien.
References
Bagi Caregiver Tentang Perawatan Orang P, Evi Martina S. DARMABAKTI CENDEKIA: Journal of Community Service and Engagements CAREGIVER TRAINING ON CARE FOR PEOPLE WITH DEMENTIA IN MEDAN, NORTH SUMATERA. Darmabakti Cendekia: Journal of Community Service and Engagements [Internet]. 2020;02:1–3. Available from: www.e-journal.unair.ac.id/index.php/DC
Arfina Program Studi AS, Payung Negeri Pekanbaru Stik. PENGARUH EDUKASI TERHADAP PENGETAHUAN MASYARAKAT TENTANG DETEKSI DINI ALZHEIMER DI KELURAHAN LABUH BARU PEKANBARU.
Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Vol. 25, Molecules. MDPI; 2020.
Agudelo-Botero M, Giraldo-Rodríguez L, Rojas-Russell ME. Systematic and Comparative Analysis of the Burden of Alzheimer’s Disease and Other Dementias in Mexico. Results at the National and Subnational Levels, 1990–2019. Journal of Prevention of Alzheimer’s Disease. 2023 Jan 1;10(1):120–9.
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022 Feb 1;7(2):e105–25.
Hajós M, Pandey K, Singer AC, Duong D, Bitarafan S, Shpokayte M, et al. CSF proteomics reveals changes in myelin and synaptic biology after Spectris treatment. Alzheimer’s and Dementia: Translational Research and Clinical Interventions. 2025 Jan 1;11(1).
Hajós M, Boasso A, Hempel E, Shpokayte M, Konisky A, Seshagiri C V., et al. Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer’s disease. Frontiers in Neurology . 2024;15.
Lahijanian M, Aghajan H, Vahabi Z. Auditory gamma-band entrainment enhances default mode network connectivity in dementia patients. Sci Rep. 2024 Dec 1;14(1).
Da X, Hempel E, Ou Y, Rowe OE, Malchano Z, Hajós M, et al. Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2024 Jan 2;97(1):359–72.
Da X, Hempel E, Brickman AM, Hajós M, Kern R, Cimenser A. SpectrisTM treatment preserves corpus callosum structure in Alzheimer’s disease. Front Neurol. 2024;15.
Chan D, Suk HJ, Jackson BL, Milman NP, Stark D, Klerman EB, et al. Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies. PLoS One. 2022 Dec 1;17(12 December).
He Q, Colon-Motas KM, Pybus AF, Piendel L, Seppa JK, Walker ML, et al. A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer’s disease. Alzheimer’s and Dementia: Translational Research and Clinical Interventions. 2021;7(1).
Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics. Vol. 14, International Journal of Nanomedicine. Dove Medical Press Ltd.; 2019. p. 5541–54.
Silva MVF, Loures CDMG, Alves LCV, De Souza LC, Borges KBG, Carvalho MDG. Alzheimer’s disease: Risk factors and potentially protective measures. J Biomed Sci. 2019 May 9;26(1).
Blanco-Duque C, Chan D, Kahn MC, Murdock MH, Tsai LH. Audiovisual gamma stimulation for the treatment of neurodegeneration. Vol. 295, Journal of Internal Medicine. John Wiley and Sons Inc; 2024. p. 146–70.
Traikapi A, Konstantinou N. Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role. Vol. 15, Frontiers in Systems Neuroscience. Frontiers Media S.A.; 2021.
Arroyo-García LE, Isla AG, Andrade-Talavera Y, Balleza-Tapia H, Loera-Valencia R, Alvarez-Jimenez L, et al. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App NL-G-F mouse model of Alzheimer’s disease. Mol Psychiatry. 2021 Oct 1;26(10):5557–67.
Deng Q, Wu C, Parker E, Zhu J, Liu TCY, Duan R, et al. Mystery of gamma wave stimulation in brain disorders. Vol. 19, Molecular Neurodegeneration . BioMed Central Ltd; 2024.
Sahu PP, Tseng P. Gamma sensory entrainment for cognitive improvement in neurodegenerative diseases: opportunities and challenges ahead. Vol. 17, Frontiers in Integrative Neuroscience. Frontiers Media S.A.; 2023.
Ichim AM, Barzan H, Moca VV, Nagy-Dabacan A, Ciuparu A, Hapca A, et al. The gamma rhythm as a guardian of brain health. Vol. 13, eLife. 2024.
Park JM, Tsai LH. Innovations in noninvasive sensory stimulation treatments to combat Alzheimer’s disease. PLoS Biol. 2025 Feb 1;23(2 February).
Adaikkan C, Tsai LH. Gamma Entrainment: Impact on Neurocircuits, Glia, and Therapeutic Opportunities. Vol. 43, Trends in Neurosciences. Elsevier Ltd; 2020. p. 24–41.
Tang Y, Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Vol. 53, Molecular Neurobiology. Humana Press Inc.; 2016. p. 1181–94.
Garza KM, Zhang L, Borron B, Wood LB, Singer AC. Gamma visual stimulation induces a neuroimmune signaling profile distinct from acute neuroinflammation. Journal of Neuroscience. 2020 Feb 5;40(6):1211–25.
Kim TH, James BT, Kahn MC, Blanco-Duque C, Abdurrob F, Islam MR, et al. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice. Sci Transl Med. 2024;16(737).
Assogna M, Sprugnoli G, Press D, Dickerson B, Macone J, Bonnì S, et al. Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: Rationale, noninvasive brain stimulation protocol, and study design. Alzheimer’s and Dementia: Translational Research and Clinical Interventions. 2021;7(1).
Manippa V, Palmisano A, Filardi M, Vilella D, Nitsche MA, Rivolta D, et al. An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment. Vol. 14, Frontiers in Aging Neuroscience. Frontiers Media S.A.; 2022.
Copyright (c) 2025 Samira Amanda, M. Ihsan, M. Nurdiansyah, Perawati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
